Synairgen Share Discussion Threads

[festario] 27/8/2020 00:23

A good post that Tickboo, and very reasonable, aside from making me smile.The convicted stalker Dean Haigh, posts several pictures of me from many years ago. And yes, on several holiday snaps, I'm sure that many of us would rather look somewhat different.However, I don't look (quite) like that these days... not that much different though in some respects, and very different in others. But one wonders why the little smelly scruff Dean Haigh fears coming down to where I live, and facing me man to man?It's because he's safe behind his little keyboard in his rancid bedsit. He knows where I live.... I don't know (quite) where he lives. So for now, he has the slight advantage.For now.

[solopsism] 26/8/2020 22:45

Tickboo

SUPERB POST 👏

[tickboo] 26/8/2020 22:16

Wow.Fest earlier -The chart now looks very fragile, it's in the stages of a collapse.All signs of accumulating have now disappeared.It should read -*My chin looks very fragile (non-existent), it's in the stage of collapse (into my neck).*All signs of accumulating have now disappeared, unlike my excess weight.

[d1nga] 26/8/2020 21:53

Another for the filtur

[lumpynidder] 26/8/2020 21:45

Fission

This ... is Fest

[sloppyjoe2] 26/8/2020 21:30

Bignads- good find. Still wouldn't surprise me if it slipped into Sep though - this isn't an exact science. Price action this afternoon suggests to me no RNS tomorrow, so that only leaves Friday. If volume and price starts spiking up after 3pm tmrw we'll know...

[bignads] 26/8/2020 21:16

We've all been scratching our heads about when the COPD results should be out and I've been a bit confused as to why everyone has been saying this month. We did find RMs oral reference to August ("next month") in the July investment presentation). On re-reading the Finncap note accompanying the trial II results, I found this on page 4 (see bottom of second para):

"The prospect of governments using SNG001 as a broad-spectrum antiviral treatment that should be stockpiled for future pandemics or used routinely to treat seasonal winter infections (influenza) where hospital pneumonia is a major issue is also increasingly likely.

"Additionally, it should enhance the prospect of the Phase II trial in COPD patients generating a positive result. As a reminder, this trial is designed to show whether SNG001 can boost anti-viral responses and minimise the worsening of COPD symptoms/lung function in patients with a confirmed respiratory viral infection. We expect Synairgen to release the interim results (109 out of 120 patients enrolled prior to the pause in enrolment due to the disruption) from this study in August."

Given that this was published on the same day as the results, they probably prepared this in advance of the announcement, suggesting this line was fed to them by the company. So, two more days to go it is then...!